CoChat

When Should a Trial of Fluoxetine for Major Depression Be Declared Failed?

Quitkin, Frederic M., Petkova, Eva, McGrath, Patrick J., Taylor, Bonnie, Beasley, Charles, Stewart, Jonathan, Amsterdam, Jay, Fava, Maurizio, Rosenbaum, Jerrold, Reimherr, Frederick, Fawcett, Jan, Chen, Ying, Klein, Donald · 2003 · American Journal of Psychiatry
Cited by 100

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Although the newer antidepressants are widely used, little is known about how long it takes to see their full effect. The authors sought to determine how many weeks a fluoxetine trial with no improvement should continue before treatment is changed. METHOD: The data involved 840 patients in a 12-week open trial of fluoxetine, 20 mg/day, followed by a blinded, placebo-controlled discontinuation study. Outcomes at 4, 6, 8, 10, and 12 weeks were classified as nonresponse, partial response, response, and remission and were based on Hamilton Depression Rating Scale scores. The rate of remission at week 12 was calculated for each group of patients without remission at the earlier time points. The time to relapse during weeks 13-26 of the discontinuation study was examined in patients taking placebo and fluoxetine in relation to status at week 6. RESULTS: Patients unimproved at week 6 had a remission rate at week 12 of 31%-41%. For patients with remission at week 12, level of improvement at week 6 did not affect prognosis in weeks 13-26. Of the unimproved patients at week 8, 23% had remissions by week 12. The week 12 remission rate for unimproved patients at week 4 was clearly high enough to justify continued treatment; the rate for unimproved patients at week 10 was too low. CONCLUSIONS: These data suggest that nonresponse to fluoxetine should not be declared until 8 weeks of treatment have elapsed. Practitioners should discuss trial length with patients at the beginning of treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.160.4.734

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 100

Metadata

Authors
Quitkin, F. M., Petkova, E., McGrath, P. J., Taylor, B., Beasley, C., Stewart, J., Amsterdam, J., Fava, M., Rosenbaum, J., Reimherr, F., Fawcett, J., Chen, Y., & Klein, D.
Venue
American Journal of Psychiatry
Published
2003-04-01
Volume
160
Issue
4
Pages
734-740
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2165222136
Cited by
100
References
2
FWCI
6.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: When Should a Trial of Fluoxetine for Major Depression Be Declared Failed? https://app.cochat.ai/papers/10.1176/appi.ajp.160.4.734
The paper
Quitkin, F. M., Petkova, E., McGrath, P. J., Taylor, B., Beasley, C., Stewart, J., Amsterdam, J., Fava, M., Rosenbaum, J., Reimherr, F., Fawcett, J., Chen, Y., & Klein, D. (2003). When Should a Trial of Fluoxetine for Major Depression Be Declared Failed? American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.160.4.734

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.